Skip to main content
Erschienen in: World Journal of Surgery 11/2007

01.11.2007

Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Polymorphisms in a Caucasian Population with Abdominal Aortic Aneurysm

verfasst von: Irene Hinterseher, Dietmar Krex, Eberhard Kuhlisch, Karl G. Schmidt, Christian Pilarsky, Wolfgang Schneiders, Hans D. Saeger, Hendrik Bergert

Erschienen in: World Journal of Surgery | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

The formation of a sporadic abdominal aortic aneurysm (AAA) is explained by the remodeling of the extracellular matrix (ECM) and breakdown of structural components of the vascular wall. Matrix metalloproteinases are the principal matrix-degrading proteases and are known to play a major role in the remodeling of the extracellular matrix in arterial vessels. Their activity is controlled by tissue inhibitors of metalloproteinases (TIMPs). Decreased TIMP-1 and TIMP-2 expression in the extracellular matrix of the walls of AAAs has been shown in several studies. This case control study was designed to investigate the possible impact of genetic variants of the TIMP-1 gene in the etiology of AAA.

Methods

TIMP-1 single nucleotide polymorphisms (SNPs) were analyzed in a primary study sample of 50 patients with AAA and 44 controls. Differences in genotype and allele frequencies of identified polymorphisms were determined after sequencing the entire coding region and selected parts of the promoter using the automated laser fluorescence technique. A second sample (96 patients vs. 89 controls) was investigated by single-base sequencing to confirm significant results.

Results

Three polymorphisms were identified, one of which, described for the first time in this article, is located in intron 4 (TIMP-1: 328 + 16> T). A statistically significant difference in allele frequencies for SNP TIMP-1 372T>C was detected in the primary study group. The C allele was more frequent in male patients with AAA than in the control group [23 vs. 4, p = 0.029, OR (95% CI) 4.38 (1.13-20.47)]. However, this result could not be confirmed in a second sample of males [52 vs. 45, p = 0.624, OR (95% CI) 1.16 (0.65-2.06)]. There were no statistically significant differences in genotype or allele frequencies of the other detected SNPs between the two groups.

Conclusions

Our analysis of the entire coding region and selected parts of the promoter of the TIMP-1 gene failed to show an association between genetic polymorphisms and AAA, suggesting that variations in the TIMP-1 gene do not contribute to the development of AAA.
Literatur
1.
Zurück zum Zitat Bickerstaff LK, Hollier LH, Van Peenen HJ, et al. (1984) Abdominal aortic aneurysms: The changing natural history. J Vasc Surg 1:6–12PubMedCrossRef Bickerstaff LK, Hollier LH, Van Peenen HJ, et al. (1984) Abdominal aortic aneurysms: The changing natural history. J Vasc Surg 1:6–12PubMedCrossRef
2.
Zurück zum Zitat Mitchell M, Rutherford R, Krupski W (1995) Infrarenal aortic aneurysms. In: Rutherford R (ed), Vascular surgery. Philadelphia, WB Saunders, pp 1032–1060 Mitchell M, Rutherford R, Krupski W (1995) Infrarenal aortic aneurysms. In: Rutherford R (ed), Vascular surgery. Philadelphia, WB Saunders, pp 1032–1060
3.
Zurück zum Zitat Darling RC III, Brewster DC, Darling RC, et al. (1989) Are familial abdominal aortic aneurysms different? J Vasc Surg 10:39–43PubMedCrossRef Darling RC III, Brewster DC, Darling RC, et al. (1989) Are familial abdominal aortic aneurysms different? J Vasc Surg 10:39–43PubMedCrossRef
4.
Zurück zum Zitat Webster EL, Ferrell RE, St. Jean PL, et al. (1991) Ultrasound screening of first-degree relatives of patients with an abdominal aortic aneurysm. J Vasc Surg 13:9–14PubMedCrossRef Webster EL, Ferrell RE, St. Jean PL, et al. (1991) Ultrasound screening of first-degree relatives of patients with an abdominal aortic aneurysm. J Vasc Surg 13:9–14PubMedCrossRef
5.
Zurück zum Zitat Johansen K, Koepsell T (1986) Familial tendency for abdominal aortic aneurysm. JAMA 256:1934–1936PubMedCrossRef Johansen K, Koepsell T (1986) Familial tendency for abdominal aortic aneurysm. JAMA 256:1934–1936PubMedCrossRef
7.
Zurück zum Zitat Superti-Furga A, Steinmann B, Ramirez F, et al. (1989) Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV. Hum Genet 82:104–108PubMedCrossRef Superti-Furga A, Steinmann B, Ramirez F, et al. (1989) Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV. Hum Genet 82:104–108PubMedCrossRef
8.
Zurück zum Zitat Tromp G, Wu Y, Prockop DJ, et al. (1993) Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms. J Clin Invest 91:2539–2545PubMed Tromp G, Wu Y, Prockop DJ, et al. (1993) Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms. J Clin Invest 91:2539–2545PubMed
9.
Zurück zum Zitat Crowther M, Brindle N, Sayers R, et al. (1996) Aneurysmal smooth muscle cells exhibit increased matrix metalloproteinase-2 production in vitro. Ann N Y Acad Sci 800:283–285PubMedCrossRef Crowther M, Brindle N, Sayers R, et al. (1996) Aneurysmal smooth muscle cells exhibit increased matrix metalloproteinase-2 production in vitro. Ann N Y Acad Sci 800:283–285PubMedCrossRef
10.
Zurück zum Zitat Freestone T, Turner RJ, Coady A, et al. (1995) Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15:1145–1151PubMed Freestone T, Turner RJ, Coady A, et al. (1995) Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15:1145–1151PubMed
11.
Zurück zum Zitat Dobrin PB, Mrkvicka R (1994) Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg 2:484–488PubMed Dobrin PB, Mrkvicka R (1994) Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg 2:484–488PubMed
12.
Zurück zum Zitat Busuttil RW, Abou-Zamzam A, Machleder HI (1980) Collagenase activity of the human aorta. Arch Surg 115:1373–1378PubMed Busuttil RW, Abou-Zamzam A, Machleder HI (1980) Collagenase activity of the human aorta. Arch Surg 115:1373–1378PubMed
13.
Zurück zum Zitat Keeling W, Armstrong P, Stone P, et al. (2005) An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 39:457–464PubMedCrossRef Keeling W, Armstrong P, Stone P, et al. (2005) An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 39:457–464PubMedCrossRef
14.
Zurück zum Zitat Sandford RM, Bown MJ, London NJ, et al. (2007) The genetic basis of abdominal aortic aneurysms: A review. Eur J Vasc Endovasc Surg 33:381–390PubMedCrossRef Sandford RM, Bown MJ, London NJ, et al. (2007) The genetic basis of abdominal aortic aneurysms: A review. Eur J Vasc Endovasc Surg 33:381–390PubMedCrossRef
15.
Zurück zum Zitat Davis VA, Persidskaia R, Baca-Regen L, et al. (1998) Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Thromb Vasc Biol 18:1625–1633 Davis VA, Persidskaia R, Baca-Regen L, et al. (1998) Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Thromb Vasc Biol 18:1625–1633
16.
Zurück zum Zitat McMillan WD, Patterson BK, Keen RR, et al. (1995) In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. J Vasc Surg 22:295–305PubMedCrossRef McMillan WD, Patterson BK, Keen RR, et al. (1995) In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. J Vasc Surg 22:295–305PubMedCrossRef
17.
Zurück zum Zitat Patel MI, Melrose J, Ghosh P, et al. (1996) Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 24:82–92PubMedCrossRef Patel MI, Melrose J, Ghosh P, et al. (1996) Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 24:82–92PubMedCrossRef
18.
Zurück zum Zitat Sakalihasan N, Delvenne P, Nusgens BV, et al. (1996) Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 24:127–133PubMedCrossRef Sakalihasan N, Delvenne P, Nusgens BV, et al. (1996) Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 24:127–133PubMedCrossRef
19.
Zurück zum Zitat Nakamura M, Tachieda R, Niinuma H, et al. (2000) Circulating biochemical marker levels of collagen metabolism are abnormal in patients with abdominal aortic aneurysm. Angiology 51:385–392PubMed Nakamura M, Tachieda R, Niinuma H, et al. (2000) Circulating biochemical marker levels of collagen metabolism are abnormal in patients with abdominal aortic aneurysm. Angiology 51:385–392PubMed
20.
Zurück zum Zitat Silence J, Collen D, Lijnen HR (2002) Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) gene. Circ Res 90:897–903PubMedCrossRef Silence J, Collen D, Lijnen HR (2002) Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) gene. Circ Res 90:897–903PubMedCrossRef
21.
Zurück zum Zitat Allaire E, Forough R, Clowes M, et al. (1998) Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 102:1413–1420PubMed Allaire E, Forough R, Clowes M, et al. (1998) Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 102:1413–1420PubMed
22.
Zurück zum Zitat Eskandari MK, Vijungco JD, Flores A, et al. (2004) Enhanced abdominal aortic aneurysm in TIMP-1-deficient mice. J Surg Res 123:289–293CrossRef Eskandari MK, Vijungco JD, Flores A, et al. (2004) Enhanced abdominal aortic aneurysm in TIMP-1-deficient mice. J Surg Res 123:289–293CrossRef
23.
Zurück zum Zitat Brophy CM, Marks WH, Reilly JM, et al. (1991) Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: A preliminary report. J Surg Res 50:653–657PubMedCrossRef Brophy CM, Marks WH, Reilly JM, et al. (1991) Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: A preliminary report. J Surg Res 50:653–657PubMedCrossRef
24.
Zurück zum Zitat Defawe OD, Colige A, Lambert CA, et al. (2003) Timp-2 and pai-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. Cardiovasc Surg 60:205–213 Defawe OD, Colige A, Lambert CA, et al. (2003) Timp-2 and pai-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. Cardiovasc Surg 60:205–213
25.
Zurück zum Zitat McMillan WD, Pearce WH (1999) Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 29:122–127; discussion 127–129PubMedCrossRef McMillan WD, Pearce WH (1999) Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 29:122–127; discussion 127–129PubMedCrossRef
26.
Zurück zum Zitat Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 1477:267–283PubMed Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 1477:267–283PubMed
27.
Zurück zum Zitat den Dunnen J, Antonarakis E (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121–124CrossRef den Dunnen J, Antonarakis E (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121–124CrossRef
28.
Zurück zum Zitat Krex D, Röhl H, König I, et al. (2003) Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms. Stroke 34:2817–2821PubMedCrossRef Krex D, Röhl H, König I, et al. (2003) Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms. Stroke 34:2817–2821PubMedCrossRef
29.
Zurück zum Zitat Jones K, Brull D, Brown L, Sian M, et al. (2001) Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103:2260–2265PubMed Jones K, Brull D, Brown L, Sian M, et al. (2001) Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103:2260–2265PubMed
30.
Zurück zum Zitat Hinterseher I, Bergert H, Kuhlisch E, et al. (2006) Matrix metalloproteinase 2 polymorphisms in a caucasian population with abdominal aortic aneurysm. J Surg Res 133:121–128PubMedCrossRef Hinterseher I, Bergert H, Kuhlisch E, et al. (2006) Matrix metalloproteinase 2 polymorphisms in a caucasian population with abdominal aortic aneurysm. J Surg Res 133:121–128PubMedCrossRef
31.
Zurück zum Zitat Yoon S, Tromp G, Vongpunsawad S, et al. (1999) Genetic analysis of MMP3, MMP9 and PAI-1 in finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 265:563–568PubMedCrossRef Yoon S, Tromp G, Vongpunsawad S, et al. (1999) Genetic analysis of MMP3, MMP9 and PAI-1 in finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 265:563–568PubMedCrossRef
32.
Zurück zum Zitat Ogata T, Shibamura H, Tromp G, et al. (2005) Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg 41:1036–1042PubMedCrossRef Ogata T, Shibamura H, Tromp G, et al. (2005) Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg 41:1036–1042PubMedCrossRef
33.
Zurück zum Zitat Armani C, Curcio M, Barsotti MC, et al. (2007) Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm. Biomed Pharmacother 61:268-271PubMedCrossRef Armani C, Curcio M, Barsotti MC, et al. (2007) Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm. Biomed Pharmacother 61:268-271PubMedCrossRef
34.
Zurück zum Zitat Fatini C, Pratesi G, Sofi F, et al. (2005) ACE dd genotype: A predisposing factor for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 29:227–232PubMedCrossRef Fatini C, Pratesi G, Sofi F, et al. (2005) ACE dd genotype: A predisposing factor for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 29:227–232PubMedCrossRef
35.
Zurück zum Zitat Tilson MD, Reilly JM, Brophy CM, et al. (1993) Expression and sequence of the gene for tissue inhibitor of metalloproteases in patients with abdominal aortic aneurysms. J Vasc Surg 18:266–270PubMedCrossRef Tilson MD, Reilly JM, Brophy CM, et al. (1993) Expression and sequence of the gene for tissue inhibitor of metalloproteases in patients with abdominal aortic aneurysms. J Vasc Surg 18:266–270PubMedCrossRef
36.
Zurück zum Zitat Wang X, Tromp G, Cole CW, et al. (1999) Analysis of coding sequences for tissue inhibitor of metalloproteinases 1 (TIMP1) and 2 (TIMP2) in patients with aneurysms. Matrix Biol 18:121–124PubMedCrossRef Wang X, Tromp G, Cole CW, et al. (1999) Analysis of coding sequences for tissue inhibitor of metalloproteinases 1 (TIMP1) and 2 (TIMP2) in patients with aneurysms. Matrix Biol 18:121–124PubMedCrossRef
37.
Zurück zum Zitat Colhoun HM, McKeigue PM, Davey Smith G (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361:865–872PubMedCrossRef Colhoun HM, McKeigue PM, Davey Smith G (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361:865–872PubMedCrossRef
38.
Zurück zum Zitat Powell JT (2006) Genes predisposing to rapid aneurysm growth. Ann N Y Acad Sci 1085:236–241PubMedCrossRef Powell JT (2006) Genes predisposing to rapid aneurysm growth. Ann N Y Acad Sci 1085:236–241PubMedCrossRef
40.
Zurück zum Zitat Rebbeck TR, Martinez ME, Sellers TA, et al. (2004) Genetic variation and cancer: Improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev 13:1985–1986PubMed Rebbeck TR, Martinez ME, Sellers TA, et al. (2004) Genetic variation and cancer: Improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev 13:1985–1986PubMed
Metadaten
Titel
Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Polymorphisms in a Caucasian Population with Abdominal Aortic Aneurysm
verfasst von
Irene Hinterseher
Dietmar Krex
Eberhard Kuhlisch
Karl G. Schmidt
Christian Pilarsky
Wolfgang Schneiders
Hans D. Saeger
Hendrik Bergert
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 11/2007
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-007-9209-x

Weitere Artikel der Ausgabe 11/2007

World Journal of Surgery 11/2007 Zur Ausgabe

Letter

Reply

Book Review

Book Review

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.